l-carnitine tmao nature medicine 2013 koeth Gut Microbiota-Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease? The gut–brain axis and trimethylamine
The gutbrain axis and trimethylamine N oxide: an emergent biomarker in neurological diseases ScienceDirect Dietary Fatty Acids Modulate Gut Microbiota Derived Trimethylamine N Oxide: Potential Mechanisms and Future Perspective Butyrobetaine is a pro atherogenic intermediate in gut microbial metabolism of L carnitine to TMAO PMC Trimethylamine N Oxide From Gut Microbiota in Chronic Kidney Disease Patients: Focus on Diet Journal of Renal Nutrition JCI l Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans
Pay in 4 interest-free payments of $5.77 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10




